Skip to content
Pay Your Membership Dues
Miami OBGYN Society
A Membership Organization of South Florida Obstetrician-Gynecologists
Miami OBGYN SocietyMiami OBGYN Society
  • About
  • Members
    • Current Fellows
  • Become a Member
  • Resources
  • News & Events
  • Contact
  • About
  • Members
    • Current Fellows
  • Become a Member
  • Resources
  • News & Events
  • Contact

FDA OKs First Targeted Therapy for Rare Blood Clotting Disorder

You are here:
  1. Home
  2. News
  3. FDA OKs First Targeted Therapy…

Caplacizumab (Cablivi) injection is indicated in combination with plasma exchange and immunosuppressive therapy for adults with acquired thrombotic thrombocytopenic purpura (aTTP).
FDA Approvals …read more

February 6, 2019

Post navigation

PreviousPrevious post:What foods are off limits while pregnant?NextNext post:Breast Implant Link to Rare T-Cell Lymphoma an Ongoing Concern
Miami OBGYN Society
Copyright © 2023 Miami OBGYN Society

Website by Jacqueline Sanchez, MD

Go to Top